[Federal Register Volume 85, Number 74 (Thursday, April 16, 2020)]
[Pages 21273-21274]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-07970]



Advisory Committee on the Medical Uses of Isotopes: Meeting 

AGENCY: U.S. Nuclear Regulatory Commission.

ACTION: Notice of Meeting.


SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) will convene a 
teleconference meeting of the Advisory Committee on the Medical Uses of 
Isotopes (ACMUI) on April 30, 2020, to discuss the draft 
recommendations of the ACMUI COVID-19 Subcommittee. The ACMUI 
subcommittee's recommendations will include its review of the impact of 
COVID-19 on the medical use community and potential regulatory relief 
measures as it relates to the medical uses of radioactive material. 
Meeting information, including a copy of the agenda and handouts, will 
be available at https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2020.html. The agenda and handouts may also be obtained by 
contacting Ms. Kellee Jamerson using the information below.

DATES: The teleconference meeting will be held on Thursday, April 30, 
2020, 2:00 p.m. to 4:00 p.m. Eastern Time.
    Public Participation: Any member of the public who wishes to 
participate in the teleconference should contact Ms. Jamerson using the 
contact information below.

FOR FURTHER INFORMATION CONTACT: Kellee Jamerson, (301) 415-7408; 
email: [email protected].


Conduct of the Meeting

    Dr. Robert Schleipman, ACMUI Vice Chairman, will preside over the 
meeting. Dr. Schleipman will conduct the meeting in a manner that will 
facilitate the orderly conduct of business. The following procedures 
apply to public participation in the meeting:
    1. Persons who wish to provide a written statement should submit an 
electronic copy to
Ms. Jamerson at the contact information listed above. All written 
statements must be received by April 27, 2020, three business days 
prior to the meeting, and must pertain to the topic on the agenda for 
the meeting.
    2. Questions and comments from members of the public will be 
permitted during the meeting at the discretion of the ACMUI Vice 
    3. The draft transcript and meeting summary will be available on 
ACMUI's website https://www.nrc.gov/reading-

[[Page 21274]]

rm/doc-collections/acmui/meetings/2020.html on or about June 15, 2020.
    This meeting will be held in accordance with the Atomic Energy Act 
of 1954, as amended (primarily Section 161a); the Federal Advisory 
Committee Act (5 U.S.C. App); and the Commission's regulations in 10 
CFR part 7.
    This meeting is being noticed in the Federal Register less than 15 
calendar days due to the immediate need to receive recommendations from 
the ACMUI to develop and provide guidance to medical use licensees 
during the COVID-19 pandemic.

    Dated: April 10, 2020.
Russell E. Chazell,
Advisory Committee Management Officer.
[FR Doc. 2020-07970 Filed 4-15-20; 8:45 am]